Literature DB >> 25868028

Reduced sensitivity of the QuantiFERON(®) test in diabetic patients with smear-negative tuberculosis.

J C Choi1, L G Jarlsberg2, J A Grinsdale3, D H Osmond4, J Higashi5, P C Hopewell2, M Kato-Maeda2.   

Abstract

SETTING: Immunosuppressive conditions have been associated with low sensitivity of interferon-gamma release assays (IGRAs) and the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB). However, no systematic analysis of patient and bacterial characteristics has been performed before.
OBJECTIVE: To determine the sensitivity and the risk factors for false-negative QuantiFERON(®)-TB (QFT) assay and TST in TB patients.
DESIGN: We performed a retrospective analysis of data collected in a community-based study of TB in San Francisco, CA, USA. We included 300 TB patients who underwent QFT and TST.
RESULTS: The risk factors for false-negative QFT were human immunodeficiency virus infection and the use of QuantiFERON(®)-TB Gold. In patients with sputum smear-negative TB, diabetes mellitus (DM) was associated with false-negative QFT (OR 2.85, 95%CI 1.02-7.97, P = 0.045). TST sensitivity was higher than QFT sensitivity in DM patients (OR 9.46, 95%CI 2.53-35.3).
CONCLUSIONS: In San Francisco, QFT sensitivity was lower than that of TST, especially in patients with DM. Stratified analysis by sputum smear results showed that this association was specific to smear-negative TB. In contrast, TST was not affected by the presence of DM.

Entities:  

Mesh:

Year:  2015        PMID: 25868028     DOI: 10.5588/ijtld.14.0553

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  QuantiFERON®-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA.

Authors:  R L Epstein; M Bhagavathula; L A Saag; S Verma; C K Kan; J Mesick; P Kamineni; L F White; E D Barnett; P Salgame; N S Hochberg
Journal:  Int J Tuberc Lung Dis       Date:  2019-04-01       Impact factor: 2.373

Review 2.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.

Authors:  Julia A Critchley; Blanca I Restrepo; Katharina Ronacher; Anil Kapur; Andrew A Bremer; Larry S Schlesinger; Randall Basaraba; Hardy Kornfeld; Reinout van Crevel
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

Review 3.  Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis.

Authors:  Guangming Chen; Huabin Wang; Yanhong Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-30       Impact factor: 3.267

4.  A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes.

Authors:  Claudia Pföhler; Michael Klotz; Thomas Wehler; Thomas Vogt; Cornelia S L Müller
Journal:  Dermatol Ther (Heidelb)       Date:  2016-11-25

5.  Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis.

Authors:  Mari Yamasue; Kosaku Komiya; Yuko Usagawa; Kenji Umeki; Shin-Ichi Nureki; Masaru Ando; Kazufumi Hiramatsu; Hideaki Nagai; Jun-Ichi Kadota
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

6.  Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study.

Authors:  Leonardo Martinez; Limei Zhu; Maria E Castellanos; Qiao Liu; Cheng Chen; Benjamin D Hallowell; Christopher C Whalen
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

7.  Predictors for false-negative QuantiFERON-TB Gold assay results in patients with extrapulmonary tuberculosis.

Authors:  Youn Jeong Kim; Ji Young Kang; Sang Il Kim; Mee Soo Chang; Yang Ree Kim; Yeon Joon Park
Journal:  BMC Infect Dis       Date:  2018-09-10       Impact factor: 3.090

8.  Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study.

Authors:  Hung-Ling Huang; Wei-Chang Huang; Kun-Der Lin; Shin-Shin Liu; Meng-Rui Lee; Meng-Hsuan Cheng; Chun-Shih Chin; Po-Liang Lu; Chau-Chyun Sheu; Jann-Yuan Wang; I-Te Lee; Inn-Wen Chong
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.